Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ãåìàòîëîãèÿ è òðàíñôóçèîëîãèÿ

Çàêðûòàÿ òåìà
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #31  
Ñòàðûé 06.10.2003, 17:27
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìàÿ Òàòüÿíà!

 òîì òî è äåëî, ÷òî íà òîêñè÷åñêîå ïîðàæåíèå ïå÷åíè ïðè òàêèõ áèîõèìè÷åñêèõ àíàëèçàõ êðîâè íå ïîõîæå, äàæå åñëè ïðåäïîëîæèòü, ÷òî ìåñÿö-2 íàçàä îíî ó Âàñ áûëî èç-çà ëåêàðñòâ. Åñëè ó Âàñ âðîæäåííîå íàðóøåíèå ãåìîñòàçà, òî îäíîâðåìåííîå íàðóøåíèå òðîìáîöèòàðíîãî è êîàãóëÿöèîííîãî çâåíà ìàëîâåðîÿòíî (ïðè áîëåçíè ôîí Âèëëåáðàíäà âñòðå÷àåòñÿ, íî íå ïðè ñóáêëèíè÷åñêîì òå÷åíèè). Åñòü ëè ó Âàñ îáèëüíûå ìåñÿ÷íûå âûäåëåíèÿ? Áûëè ëè îïåðàöèè, óäàëåíèå çóáîâ, íå ñîïðîâîæäàëîñü ëè ýòî äëèò.êðîâîòå÷åíèåì?  àíàëèçàõ òåíäåíöèÿ ê ñíèæåíèþ ÷èñëà òðîìáîöèòîâ (â íà÷àëå ìåñÿöà 780, â êîíöå 600), ïîõîæå ÷òî âñå æå ðåàêòèâíûé òðîìáîöèòîç. Íî ÏÒÈ è ÌÍÎ, à òàêæå äàííûå ÒÝà íóæíî áóäåò ïîâòîðèòü ñïóñòÿ ìåñÿö. Êðîìå äèíàìè÷åñêîãî íàáëþäåíèÿ ïîêà íèêàêèõ ñîâåòîâ äàòü íå ìîãó, êàê ñåé÷àñ ñ ãîëåíÿìè è âåíàìè, íå äåëàëè ëè ÓÇÈ ãëóá. âåí?
  #32  
Ñòàðûé 07.10.2003, 09:30
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Çäðàâñòâóéòå!
ÓÇÈ íîã ÿ äåëàëà 1,5 íåäåëè íàçàä. Íàïóãàííàÿ òàêèìè òðîìáîöèòàìè è áîëÿìè, ÿ ïîáåæàëà ê ôëåáîëîãó. Âðà÷ ñêàçàë, ÷òî íà äàííûé ìîìåíò âåíû è êëàïàíû ðàáîòàþò íîðìàëüíî, íî ïî ëåâîé íîãå (êîòîðàÿ áîëåëà) ïðîãíîç ïëîõîé - âàðèêîç ñî âðåìåíåì áóäåò, ñàìàÿ ãëàâíàÿ âåíà íå î÷åíü (íåóäèâèòåëüíî, ó ìåíÿ íàñëåäñòâåííîñòü ñîîòâåòñòâóþùàÿ), ñåé÷àñ ìíå äåëàþò ïðîöåäóðó ôëåáîñêëåðîçèðîâàíèÿ íà ýòîé íîãå, íà íî÷ü ïåðåâÿçûâàþ åå ýëàñòè÷íûì áèíòîì, äíåì - òðèêîòàæ. Áîëè óæå íåò, òÿæåñòü òîæå ïðîïàëà. Çóáû ÿ íå óäàëÿëà íèêîãäà, ëå÷èëà â íà÷àëå ìàðòà (óäàëÿëè íåðâû). Ìåíñòðóàöèÿ âñåãäà ñîïðîâîæäàåòñÿ îáèëüíûìè âûäåëåíèÿìè â òå÷åíèå ïåðâîãî è âòîðîãî äíÿ, çàòåì çíà÷èòåëüíî ñíèæàåòñÿ, íî âñå ðàâíî ïðîäîëæàåòñÿ 7 äíåé, âåñü öèêë - 30-31 äåíü.  ïîñëåäíèå 4 ìåñÿöà öèêë ñëåãêà ñáèëñÿ, ñòàë 26-28 äíåé, íî ñåé÷àñ îïÿòü âîçâðàùàåòñÿ ê ïðåæíèì çíà÷åíèÿì. Åñëè ýòî èìååò êàêîå-òî çíà÷åíèå, òî åùå ó ìåíÿ ñòîèò äèàãíîç - ìèãðåíü ñ àóðîé, êòî-òî ãîâîðèò, ÷òî ýòî ïðîñòî âåãåòî-ñîñóäèñòàÿ äèñòîíèÿ. Ïðèñòóï íà÷èíàåòñÿ ñ ìåðöàíèÿ â ãëàçàõ, êàê ïîìåõè â òåëåâèçîðå, ïîòîì áûâàåò, ÷òî ñâîäèò ðóêó (íî íå ÷àñòî), íà÷èíàÿ ñ ïàëüöåâ, äîõîäèò äî ïëå÷à, íîñà, ÿçûêà, äåñåí. Ïðîäîëæàåòñÿ ýòî âñå âìåñòå ãäå-òî â òå÷åíèå ïîëó÷àñà, ïîòîì ãîëîâíàÿ áîëü â âèñêå, êîòîðóþ ÿ, êàê ïðàâèëî, ñíèìàþ öèòðàìîíîì èëè ëþáûì àíàëüãåòèêîì. Ýòî ó ìåíÿ ëåò ñ 9-10. Îáû÷íî ïðèñòóï ñâÿçàí ñî ñëèøêîì ðåçêîé ïåðåìåíîé ïîãîäû èëè, åñëè ñèëüíî ïîíåðâíè÷àþ, ò.å íèêàêîãî îòíîøåíèÿ ê ìåíñòðóàëüíîìó öèêëó íå èìååò. Îïåðàöèé íèêîãäà íèêàêèõ íå áûëî. Ïîëüçóÿñü Âàøåé îòçûâ÷èâîñòüþ, õîòåëîñü áû ïîáîëüøå óçíàòü, ÷åì îïàñíî ýòî çàáîëåâàíèå, ñâÿçàííîå ñ ïëîõîé ñâåðòûâàåìîñòüþ êðîâè, ò.ê. ÿ âñåãäà ýòî ó ñåáÿ ïîäîçðåâàëà? Åñòü ëè ïðè òàêèõ àíàëèçàõ óãðîçà òðîìáîçîâ (ñ ÷åì ñâÿçàí Âàø âîïðîñ î âåíàõ íîã)? Îãðîìíîå ñïàñèáî çà âíèìàíèå.
Ñ óâàæåíèåì, Òàòüÿíà.
  #33  
Ñòàðûé 07.10.2003, 11:05
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Çäðàâñòâóéòå, Òàòüÿíà!

Ñðàçó íåñêîëüêî âîïðîñîâ: êîãäà Âû âïåðâûå îòìåòèëè ïîâûøåííîå ñîäåðæàíèå òðîìáîöèòîâ, èññëåäîâàëîñü ëè êîãäà ðàíåå êîëè÷åñòâî Âàøèõ òðîìáîöèòîâ è åñëè äà, òî êàêèå öèôðû? Ïåðå÷èñëèòå, âñå âîçìîæíûå ëåêàðñòâà, êîòîðûå Âû ïðèíèìàëè íàêàíóíå ñäà÷è àíàëèçîâ ïî ñâåðòûâàíèþ, âêëþ÷àÿ ïðåäûäóùèõ 5-6 äí.? Êîãäà íà÷àëàñü ïðîöåäóðà ñêëåðîçèðîâàíèÿ è êàêèå ìåäèêàìåíòû Âàì íàçíà÷èëè â ñâÿçè ñ ýòèì? Ïðè óïîìèíàíèè ëåêàðñòâ, êðîìå ôèðìåííîãî íàçâàíèÿ, íàïèøèòå, ÷òî ñîäåðæèòñÿ â êàæäîé òàáëåòêå â ìã. Íå áûëî ëè ó Âàñ ìèãðåíîçíîãî ïðèñòóïà íàêàíóíå (â òå÷åíèå 5-6 äí.) ñäà÷è àíàëèçîâ? Åñëè äà, êàêîé ïðåïàðàò èñïîëüçîâàëè äëÿ ñíÿòèÿ?

Ïî Âàøèì âîïðîñàì ñëåäóþùåå: åñëè ýòî äåéñòâèòåëüíî ìèãðåíü, òî âïîëíå âåðîÿòíî, ÷òî èìååòñÿ êàêîå ëèáî âðîæäåííîå íàðóøåíèå ñâåðòûâàíèÿ êðîâè, ïðåäðàñïîëàãàþùåå ê òðîìáîçàì (÷òî ñîâñåì íå "ïèøåòñÿ" ñ ðåçóëüòàòàìè Âàøèõ àíàëèçîâ), êðîìå òîãî ìèãðåíü èëè äð. ïðîÿâëåíèÿ ìîãóò áûòü ýêâèâàëåíòàìè âðåìåííîãî/òðàíçèòîðíîãî íàðóøåíèÿ ìîçãîâîãî êðîâîîáðàùåíèÿ è íå ðåäêî âñòðå÷àþòñÿ ïðè èñòèííîé òðîìáîöèòåìèè; íàèáîëåå íåïðèÿòíî, ÷òî ýòî ìîæåò îñëîæíÿòüñÿ/çàêàí÷èâàòüñÿ èøåìè÷åñêèìè èíñóëüòàìè (ñòîéêîå íàðóøåíèå ìîçãîâîãî êðîâîîáðàùåíèÿ, ïðèâîäÿùåå ê "îòìèðàíèþ"/èíôàðêòó ó÷àñòêà ãîëîâíîãî ìîçãà, àíàëîãè÷íîå èíôàðêòó ìèîêàðäà â ñåðäöå). Âñå ýòî êðàéíå ñåðüåçíî, ïîýòîìó ïðîøó Âàñ âíèìàòåëüíî îòíåñòèñü ê íàïèñàíèþ è ïîñòàðàòüñÿ îòìåòèòü âñå íþàíñû Âàøåãî çäîðîâüÿ è ðîäñòâåííèêîâ (íàñëåäñòâåííîñòü), äàáû ïîïûòàòüñÿ ñîñòàâèòü íàèáîëåå ïîëíóþ êàðòèíó, î òîì ñ êåì è ÷åì ìû èìååì äåëî, ó÷èòûâàÿ âåñüìà ñïåöèôè÷íîñòü âðà÷. êîíñóëüòàöèé â è-íåòå.
  #34  
Ñòàðûé 07.10.2003, 12:46
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Îõî-õî, ñåé÷àñ óæå äîñòàòî÷íî ñëîæíî âñïîìíèòü, ÷òî èìåííî ÿ ïðèíèìàëà íàêàíóíå àíàëèçà. Ïðèñòóï ó ìåíÿ, êàæåòñÿ, áûë, íî äíåé çà 5-6 äî àíàëèçà. Äëÿ ñíÿòèÿ ïðèñòóïà ïðèíèìàëà êåòàíîâ, íî åãî ñîñòàâëÿùèå íå çíàþ, 1 òàáëåòêó. Äàâëåíèå îáû÷íî ó ìåíÿ íîðìàëüíîå äàæå âî âðåìÿ ïðèñòóïà, ëèáî ïîíèæåííîå. Ïðîöåäóðó ñ íîãàìè íà÷àëè 27 ñåíòÿáðÿ, íî ïîñëå ñäà÷è àíàëèçà. Íèêàêèõ ïðåïàðàòîâ äîïîëíèòåëüíî ìíå íå íàçíà÷àëè, à ÷òî êîíêðåòíî âêàëûâàþò, íå çíàþ, íî ìîãó óòî÷íèòü. Îáùèé àíàëèç êðîâè íå ñäàâàëà íåñêîëüêî ëåò (ãîäà 3), ïîýòîìó òàêîé óðîâåíü òðîìáîöèòîâ óâèäåëà òîëüêî 4 ñåíòÿáðÿ. Èç íàñëåäñòâåííîãî: óçëîâîé çîá (ó ìàìû), ïðåäðàñïîëîæåííîñòü ê âàðèêîçó (îò îáîèõ ðîäèòåëåé), ãîëîâíûå áîëè áûâàþò ó îáîèõ, íî íè÷åãî ïîäîáíîãî íåò, ó îòöà áûëè â ïî÷êàõ êàìíè è òàõèêàðäèÿ, ñïàéêè êèøå÷íèêà ó ìàìû. Îáî âñåõ ïóãàþùèõ ïîñëåäñòâèÿõ ìèãðåíè ÿ, êîíå÷íî, óæå ñëûøàëà, íî âåäü íèêàêîãî ëå÷åíèÿ ìèãðåíè, íàñêîëüêî ìíå èçâåñòíî íå ñóùåñòâóåò. Äåòñêèé íåâðîïàòîëîã, êîòîðûé íàáëþäàë ìåíÿ, ñíà÷àëà ñêàçàë, ÷òî âñå ïðîéäåò ïîñëå íà÷àëà ðåãóëÿðíîé ïîëîâîé æèçíè, è ïðàâäà, ïîëåã÷àëî, ñèëüíûõ ïðèñòóïîâ ïî÷òè íå ñòàëî, êàê ïðàâèëî áûâàåò 1 ïðèñòóï â ìåñÿö, âåñíîé è îñåíüþ ÷àùå. Ïîçäíåå íåâðîïàòîëîã ñòàëà ãîâîðèòü, ÷òî ðîäèòå, îðãàíèçì îáíîâèòñÿ è âñå ïðîéäåò. Åñëè íóæíû åùå êàêèå-òî äàííûå ñïðàøèâàéòå. Àõ, äà ãèíåêîëîã ïîñëå ëå÷åíèÿ áàêòåðèàëüíîãî âàãèíîçà íàçíà÷èëà ïèòü áèôèäîáàêòåðèí, 3 ðàçà â äåíü ïî 5 äîç. Âîò åãî ÿ ñåé÷àñ è ïðèíèìàþ.  ÷åòâåðã áóäó äåëàòü åùå ðàç ÓÇÈ áðþøíîé ïîëîñòè, ñêàçàëè ïèòü àêòèâèðîâàííûé óãîëü, åãî-òî ìîæíî?  ñâîå âðåìÿ ìíå ãîâîðèëè, ÷òî ãîëîâíàÿ áîëü ó ìåíÿ èç-çà çàùåìëåíèÿ êàêîãî-òî íåðâà â øåå (âîçìîæíî ðîäîâàÿ òðàâìà), îñåíüþ è âåñíîé ó ìåíÿ ïîáàëèâàåò øåÿ, áîëüíî ïîâîðà÷èâàòü, ñåé÷àñ ïîêà íå áîëèò.  äåòñòâå ãîëîâîé óäàðÿëàñü è íå îäèí ðàç, íî ñîòðÿñåíèÿ íå áûëî, õîòÿ èññëåäîâàíèÿ ïîêàçûâàëè , ÷òî, âîçìîæíî, êîãäà-òî áûëà òðàâìà, âñå ýòè èññëåäîâàíèÿ ïðîâîäèëà î÷åíü äàâíî, ëåò â 17, ñåé÷àñ ìíå 25.
  #35  
Ñòàðûé 07.10.2003, 13:44
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êåòàíîâ (òðîìåòàìèíà êåòîðîëàê) âûçûâàåò äëèòåëüíîå óãíåòåíèå ôóíêöèè òðîìáîöèòîâ (ïîõîæåå íà àñïèðèí), ïîýòîìó âïîëíå âåðîÿòíûì ìîæåò áûòü, ÷òî ðåçóëüòàòû àãðåãàöèè òðîìáîöèòîâ à òàêæå ÒÝà âûçâàíû èìåííî ýòèì è íå ÿâëÿþòñÿ ïîñòîÿííûìè. Áîëåå íåïîíÿòíûì ÿâëÿþòñÿ Âàøè èçìåíåíèÿ â êîàãóëîãðàììå, òê êåòàíîâ èëè äð. ÍÏÂÑ íå îêàçûâàþò âëèÿíèÿ íà ýòè ïàðàìåòðû. Íå íàçíà÷àëè ëè Âàì ôëåáîëîãè êàêîé ëèáî ïðåïàðàò ïåðåä íà÷àëîì ôëåáîñêëåðîçèðîâàíèÿ (çà äåíü-2 èëè íå êîëîëè ëè ÷åãî)?
 âåäåíèè ìèãðåíè âûäåëÿþò ëå÷åíèå îñòðîãî ïðèñòóïà è ìåäèêàìåíòîçíàÿ ïðîôèëàêòèêà ïðèñòóïîâ. Âòîðîé âàðèàíò ìîã áû Âàì ïîäîéòè, åñëè Âû çàõîòèòå ïðèíèìàòü ëåêàðñòâà ïîñòîÿííî èõ ïðèåì äîëæåí ïðåäîòâðàùàòü ó Âàñ ïðèñòóïû è âîçìîæíî ïðåäîòâðàòèòü/îòñðî÷èòü ðàçâèòèå îñëîæíåíèé. Åñëè ñîãëàñíû ñ ýòèì, òî ìîæíî â äàëüíåéøåì îáñóäèòü âàðèàíòû. È åùå: êàêîé èç ïðåïàðàòîâ ïî Âàøåìó îïûòó íàèáîëåå õîðîøî ñíèìàåò ïðèñòóï: äîçà, êðàòíîñòü äîçû, âðåìÿ äî êóïèðîâàíèÿ?
Àêòèâèðîâàííûé óãîëü ïèòü ìîæíî. Ïî ïîâîäó áîëåé â øåéíîì îòäåëå ñêàçàòü çàòðóäíÿþñü, åñòü íàáëþäåíèÿ, ÷òî ãîë. áîëü ïëþñ øóì â óøàõ è áîëè â øåéíîì îòäåëå ìîãóò âñòðå÷àòüñÿ ïðè ïîâûøåíèè âíóòðè÷åðåïíîãî äàâëåíèÿ, íî äëÿ ýòîãî íåîáõîäèìî äîîáñëåäîâàíèå ó íåâðîïàòîëîãà/îêóëèñòà.
  #36  
Ñòàðûé 07.10.2003, 14:18
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Ê ôëåáîëîãàì ÿ ïîïàëà óæå ïîñëå ñäà÷è àíàëèçà, ïîýòîìó íèêàêèå èõ ïðåïàðàòû íå ìîãëè ïîâëèÿòü íà ðåçóëüòàòû. Íàñ÷åò ìèãðåíè áûëà áû áëàãîäàðíà çà ëþáûå ðåêîìåíäàöèè. ß íå ìîãó ñêàçàòü, ÷òî îíà êàê-òî ñèëüíî îñëîæíÿåò ìíå æèçíü íà äàííûé ìîìåíò, ò.ê. ìàêñèìóì îíà âûáèâàåò ìåíÿ èç ðàáî÷åé êîëëåè íà ïîë÷àñà-÷àñ, à ÿ ñëûøàëà, ÷òî ëþäè ñòðàäàþò öåëûìè äíÿìè. Íî âñå ðàâíî ñèìïòîìû, êîòîðûå ó ìåíÿ åñòü, êîíå÷íî, ïóãàþò ìåíÿ, îñîáåííî îíåìåíèå. ×òîáû ñíÿòü áîëü, ìíå äîñòàòî÷íî ïðèíÿòü 1 òàáëåòêó öèòðàìîíà+íî-øïà (êòî-òî ïîñîâåòîâàë íå ïðèíèìàòü öèòðàìîí â ÷èñòîì âèäå), àñêîôåí, åñëè áîëü ñèëüíåå îáû÷íîãî, òî îäíîé òàáëåòêè ëþáîãî àíàëüãåòèêà (êåòàíîâ, àíàëüãèí, áàðàëãèí, òåìïàëãèí, íóðîôåí) äîñòàòî÷íî.  äåòñòâå çàñòàâëÿëè ïèòü íàñòîéêó ïèîíà, íî ÿ åå íà äóõ íå âûíîøó. Âû äóìàåòå, ÷òî óæàñíûå ïîñëåäñòâèÿ ìèãðåíè, î êîòîðûõ Âû óïîìèíàëè, íåìèíóåìû? ×òî-òî ìîæíî ïðåäïðèíÿòü äëÿ òîãî, ÷òîáû èçáåæàòü èõ? Ñëûøàëà, ÷òî ñåé÷àñ äëÿ ñíÿòèÿ ïðèñòóïà ïîÿâèëèñü êàêèå-òî ñïðåè, ó íèõ åñòü êàêèå-òî ïëþñû? Ïðîáîâàëà ïðèíèìàòü òàáëåòêè â ñàìîì íà÷àëå ïðèñòóïà, ò.å. êîãäà ìåðöàåò â ãëàçàõ, íî òùåòíî, ïîýòîìó äîæèäàþñü îêîí÷àíèÿ ìåðöàíèÿ, îíåìåíèÿ (åñëè îíî ñëó÷àåòñÿ) è ïðèíèìàþ òàáëåòêó. Øóìà â óøàõ ó ìåíÿ íå áûëî, ó îôòàëüìîëîãà áûëà 2 ãîäà íàçàä, âíóòðè÷åðåïíîå äàâëåíèå áûëî â íîðìå. Åùå îäèí âîïðîñ: ó ìåíÿ ïîêà íåò äåòåé, íî â áóäóùåì î÷åíü õîòåëîñü áû èõ èìåòü. Ïîíÿòíî, ÷òî ïðè ìîåé íåÿñíîé ñèòóàöèè ñåãîäíÿ îá ýòîì ïîêà íå èäåò ðå÷ü, è âñå æå. Òàêàÿ ìèãðåíü, âîçìîæíî ïëîõàÿ ñâåðòûâàåìîñòü êðîâè íå ñàìîå ëó÷øåå äëÿ áóäóùåé ìàìû è ðåáåíêà. ×òî áû Âû ðåêîìåíäîâàëè ïðîâåðèòü ïðè ïëàíèðîâàíèè áåðåìåííîñòè? Åùå ðàç ñïàñèáî.
  #37  
Ñòàðûé 07.10.2003, 15:34
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íàñ÷åò ïðîôèëàêòèêè ìèãðåíè ñèòóàöèÿ ñëåäóþùàÿ: ñíà÷àëà æåëàòåëüíî çàâåñòè äíåâíèê è îòìå÷àòü ÷àñòîòó ïðèñòóïîâ, äëèòåëüíîñòü è èíòåíñèâíîñòü àóðû, ãîëîâíîé áîëè, çàòåì íà÷èíàòü ïðîôèëàêòèêó ñ ìàëûõ äîç ïðåïàðàòà: èìè ìîãóò áûòü èëè ìåòîïðîëîë (ýãèëîê, ìåòàêàðä) èëè ïðîïðàíîëîë /îáçèäàí/ (èç ãðóïïû áåòà-áëîêàòîðîâ), ïîýòîìó ëó÷øå ïðèîáðåñòè ïðåïàðàò íåäîðîãîé (íè íå îòå÷åñòâåííûé è íå èíäèéñêèé)â áîëüøåé äîçå (íå ðåòàðäíûé) è íà÷àòü ñ 1/2-1/4 òàáë. (íà÷. äîçà äëÿ ïðîïðàíîëîëà 20-40 ìã, äëÿ ìåòîïðîëîëà 25-50 ìã â ñóòêè), ñëåäóåò, ÷òî áû äîçà ïðåïàðàòà íå âûçûâàëà áðàäèêàðäèè (çàìåäëåíèÿ ñåðä. ðèòìà ìåíåå 60-65 óä. â ïîêîå), íå ïðîâîöèðîâàëà çàòðóäíåíèå äûõàíèÿ (ïðè íàçíà÷åíèè ïðîïðàíîëîëà), íî â òî æå âðåìÿ ñíèçèëà ÷àñòîòó è èíòåíñèâíîñòü ïðèñòóïîâ. Òàêæå ìîæíî ïîïðîáîâàòü äîáàâèòü ìàëóþ äîçó àñïèðèíà (1/4 òàáë. ñîä. 325-500 ìã), õîòÿ ïîëîæèòåëüíûé ýôôåêò îòìå÷àëñÿ ïðè êàæäîì èç ïðåïàðàòîâ, åñòü âåðîÿòíîñòü, ÷òî ñî÷åòàíèå àñïèðèíà è áåòà-áëîêàòîðà áóäåò âçàèìîóñèëÿþùèì è ïîçâîëèò äîáèòüñÿ ñòîéêîãî ýôôåêòà ïðè íåáîëüøèõ äîçàõ îáîèõ ïðåïàðàòîâ. Ýòè îáà ïðåïàðàòà äîñòîâåðíî ñíèæàþò ðèñê ðàçâèòèÿ íàðóøåíèé ìîçãîâîãî êðîâîîáðàùåíèÿ.
Ñïðåè íè÷åãî Âàì, êðîìå ðàñòðàò, â êóïèðîâàíèè ïðèñòóïîâ íå äàäóò, åñëè ïîìîãàþò àíàëüãåòèêè èëè ÍÏÂÑ.
Äî íà÷àëà áåðåìåííîñòè áûëî áû íåïëîõî âûÿâèòü ïðè÷èíû óâåëè÷åíèÿ ÏÒÈ, ÌÍÎ, êñòàòè íå ìîãëè áû Âû âûÿñíèòü â ëàáîðàòîðèè íîðìàëüíûå âåëè÷èíû äëÿ äàííîãî àíàëèçà:

Òðîìáîïëàñòèíîâîå âðåìÿ 55,5
Êàîëèíîâîå âðåìÿ 52,4
Çìåèíûé ÿä 47,3

Çàêëþ÷åíèå: âîë÷àíî÷íûé àíòèêîàãóëÿíò íå îáíàðóæåí

È êàêèå ó íèõ ïðèìåðíî öèôðû, êîãäà âîë÷àíî÷íûé àíòèêîàãóëÿíò âûÿâëÿåòñÿ?
  #38  
Ñòàðûé 07.10.2003, 16:07
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
ñïàñèáî Âàì çà ðåêîìåíäàöèè ïî ìèãðåíè. Íî ïîêà íå âûÿñíåíî, ÷òî ñ êðîâüþ, ÿ áîþñü ïðèíèìàòü êàêèå-ëèáî ïðåïàðàòû. Ê òîìó æå ó ìåíÿ áûâàåò ó÷àùåííîå ñåðäöåáèåíèå, íå ñêàæóòñÿ ëè ïðåïàðàòû íåãàòèâíî íà ñåðäå÷íîé äåÿòåëüíîñòè (Âû íàïèñàëè, ÷òî çàìåäëåíèå âîçìîæíî)? Êàðäèîãðàììó äåëàëà âåñíîé, îíà â ïîðÿäêå, íî ïðîñëóøèâàþòñÿ øóìû. Åñëè ïðèíèìàòü ýòè ïðåïàðàòû, òî âñå âðåìÿ èëè â íà÷àëå ïðèñòóïà? Êàê äîëãî íàáëþäàòü ïðåæäå ÷åì, ïðèñòóïèòü ê ïðèåìó ëåêàðñòâ?
Ïî ïîâîäó íîðìàòèâíûõ çíà÷åíèé äëÿ âîë÷àíî÷íîãî àíòèêîàãóëÿíòà íàïèøó çàâòðà, ïðè ñåáå íåò àíàëèçà. Íî òàì âñå ïîêàçàòåëè â íîðìå, òîëüêî ïåðâûé èç íèõ íà ñàìîé âåðõíåé ãðàíèöû íîðìû. Ïðè íàçíà÷åíèè ýòîãî àíàëèçà âðà÷ ñïðàøèâàë ìåíÿ î ñàìîïðîèçâîëüíûõ âûêèäûøàõ ó ìåíÿ è ó áëèæàéøèõ ðîäñòâåííèêîâ. Íè ó ìåíÿ, íè ó ìàìû, íè ó ðîäíîé òåòêè òàêîãî íå áûëî.
Ñ óâàæåíèåì, Òàòüÿíà.
  #39  
Ñòàðûé 07.10.2003, 16:32
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ðå÷ü øëà î ïðîôèëàêòèêå, ò å ïîñòîÿííûé ïðèåì, íàïðàâëåííûé íà ïðåäîòâðàùåíèå ïðèñòóïîâ è âåðîÿòíî îñëîæíåíèé. Ïåðåä íà÷àëîì ïðèåìà íóæíî îïðåäåëèòüñÿ êàê ÷àñòî áûâàþò ó Âàñ ïðèñòóïû è èõ ïðîäîëæèòåëüíîñòü, èìåÿ ýòè äàííûå, íà ôîíå ïðîôèëàêòèêè Âû ìîæåòå îòìå÷àòü äåéñòâèòåëüíî èõ ñòàëî ìåíüøå èëè òàêàÿ æå ÷àñòîòà. Æåëàòåëüíî, ÷òî áû áûëî íå ìåíåå 2 ïðèñòóïîâ â ìåñÿö, ÷òî áû äîñòîâåðíî îòìåòèòü, ÷òî ïðîôèëàêòèêà äàåò ñâîè ïðåèìóùåñòâà. Åñëè âäàâàòüñÿ â òîíêîñòè, òî â ñòðåññîâûõ ñèòóàöèÿõ, êîòîðûå ïðîâîöèðóþò ó Âàñ ïðèñòóïû è âåðîÿòíî ñîïðîâîæäàþòñÿ ñåðäöåáèåíèåì, ïðîèñõîäèò àäðåíåðãè÷åñêàÿ àêòèâàöèÿ, ïîýòîìó íàçíà÷åíèå áåòà-áëîêàòîðîâ ìîãëî áû áëîêèðîâàòü èçëèøíþþ ñòèìóëÿöèþ íà ñåðäöå è âåðîÿòíî íà ñîñóäû ãîë. ìîçãà.
  #40  
Ñòàðûé 07.10.2003, 16:50
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Ïðîñòèòå ìîþ âúåäëèâîñòü, íî õîòåëîñü áû çíàòü, äàþò ëè ïåðå÷èñëåííûå ïðåïàðàòû êàêèå-òî ïîáî÷íûå ÿâëåíèÿ? Èíòåðåñóåò ïîòåíöèàëüíîå âëèÿíèå íà ïå÷åíü, êðîâü, ÙÆ. Íàñêîëüêî ÿ ïîíèìàþ, ïðåïàðàòû äîñòàòî÷íî ñèëüíûå. À òî ó ìåíÿ ïîëó÷àåòñÿ, ÷òî ÿ îäíî ëå÷ó, äðóãîå êàëå÷ó.
Ñïàñèáî.
  #41  
Ñòàðûé 07.10.2003, 17:36
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðîïðàíîëîë áûë çàìå÷åí â íàðóøåíèè òðàíñïîðòà èîäà â ôîëëèêóëàõ ÙÆ, ìåòîïðîëîë - íåò è íå âëèÿë íà ñîäåðæàíèå ãîðìîíîâ ÙÆ. Äëÿ ïå÷åíè è êðîâè â òåðàïåâòè÷åñêèõ äîçàõ îáà ïðåïàðàòà áåçîïàñíû.
  #42  
Ñòàðûé 08.10.2003, 10:38
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Äîáðûé äåíü!
Êàê è îáåùàëà, ñîîáùàþ íîðìû ïî âîë÷àíî÷íîìó àíòèêîàãóëÿíòó:
Òðîìáîïëàñòèíîâîå âðåìÿ - 55,5 ( äî 45-55) ñåê.
Êàîëèíîâîå âðåìÿ - 52,4 (äî 89) ñåê.
Çìåèíûé ÿä - 47,3 (äî 45-55) ñåê.

À ïî ìèãðåíè, åùå õîòåëà ñïðîñèòü: êàê Âû îòíîñèòåñü ê ãîìåîïàòè÷åñêèì ñðåäñòâàì åå ëå÷åíèÿ? Ñëûøàëà, ÷òî â íà÷àëå èõ ïðèåìà îáîñòðÿåòñÿ ÷àñòîòà è èíòåíñèâíîñòü ïðèñòóïîâ, íî ïîòîì ÿêîáû äîñòèãàåòñÿ ñòîéêèé
  #43  
Ñòàðûé 08.10.2003, 10:40
TSh TSh âíå ôîðóìà
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 21.06.2003
Ãîðîä: ìîñêâà
Ñîîáùåíèé: 207
Ñêàçàë(à) ñïàñèáî: 40
TSh ýòîò ó÷àñòíèê ïîëîæèòåëüíî õàðàêòåðèçóåòñÿ íà ôîðóìå
Äîáðûé äåíü!
Êàê è îáåùàëà, ñîîáùàþ íîðìû ïî âîë÷àíî÷íîìó àíòèêîàãóëÿíòó:
Òðîìáîïëàñòèíîâîå âðåìÿ - 55,5 ( äî 45-55) ñåê.
Êàîëèíîâîå âðåìÿ - 52,4 (äî 89) ñåê.
Çìåèíûé ÿä - 47,3 (äî 45-55) ñåê.

À ïî ìèãðåíè, åùå õîòåëà ñïðîñèòü: êàê Âû îòíîñèòåñü ê ãîìåîïàòè÷åñêèì ñðåäñòâàì åå ëå÷åíèÿ? Ñëûøàëà, ÷òî â íà÷àëå èõ ïðèåìà îáîñòðÿåòñÿ ÷àñòîòà è èíòåíñèâíîñòü ïðèñòóïîâ, íî ïîòîì ÿêîáû äîñòèãàåòñÿ ñòîéêèé ïîëîæèòåëüíûé ýôôåêò?
  #44  
Ñòàðûé 08.10.2003, 11:40
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äîáðûé äåíü, Òàòüÿíà!

ñïàñèáî, âîïðîñ îñòàåòñÿ îòêðûòûì: ïî÷åìó ó Âàñ óâåëè÷åíû áûëè ÏÒÈ, ÌÍÎ, ïðè íîðìàëüíûõ äð. òåñòàõ îáüÿñíåíèå òîëüêî îäíî - äåôèöèò ôàêòîðà VII. äàáû óäîñòîâåðèòñÿ â ýòîì, ïîñëå ôëåáîïðîöåäóð ÷åðåç íåäåëþ-äðóãóþ áåç âñÿêèõ ëåêàðñòâ è òàáëåòîê îò ãîëîâíîé áîëè ïåðåñäàéòå ýòè è æåëàòåëüíî åùå ðàç À×ÒÂ.
Íàñ÷åò ãîìåîñðåäñòâ ëó÷øå ïðîêîíñóëüòèðîâàòüñÿ ñ ãîìåîïàòîì è æåëàòåëüíî íå îäíèì, ÷òî áû ïîëó÷èòü íåñêîëüêî ìíåíèé.
Çàðóáåæíûå ìíåíèÿ çäåñü:

Schmerz. 1996 Jun 17;10(3):156-62.

[Homeopathy in headaches. A review]

Walach H, Haag G.

Universitat Freiburg, Rehabilitationspsychologie, D-79 085 Freiburg.

Homeopathy as an alternative to conventional therapy is becoming increasingly popular. Although interest is rising, little is known about the real effectiveness of homeopathic therapy in headaches. Three studies addressing this question are discussed: an Italian migraine study, the London migraine study and our own, the Munich headache trial. While the first one reported very high effects, the best ones known in the literature, the results of the other two trials do not endorse this first finding. The London trial did not show any effect other than placebo, although a different time trend was reported. The Munich study failed to show any difference between homeopathy and placebo whatsoever. The merits and shortcomings of these studies are discussed. At present, we do not have any evidence that homeopathic therapy has any effect other than a placebo effect. However, this can be very impressive sometimes. We do not know which variables are correlated with placebo effectiveness, and we do not have any data on real-type homeopathy outside a trial setting, as there are no data available.


Br Homeopath J. 2000 Jan;89(1):4-7.

Homeopathic treatment of migraine: a double blind, placebo controlled trial of 68 patients
Straumsheim P, Borchgrevink C, Mowinckel P, Kierulf H, Hafslund O.

Arena Medisinske Senter, Sognsveien, Oslo, Norway.

To evaluate the efficacy of homeopathy in preventing migraine attacks and accompanying symptoms, a randomised, double-blind, placebo-controlled clinical trial was conducted. There was a one-month registration period without treatment, followed by four months individualised homeopathic treatment or identical placebo. Patients were stratified for common or classical migraine. Seventy-three patients were randomised, 68 completed the trial. Baseline values were similar in the two groups. Both the homeopathy and placebo groups had reduction in attack frequency, pain intensity and drug consumption, with a statistically non-significant difference favouring homeopathy. Migraine diaries showed no difference between groups. The neurologists' trial evaluation showed a statistically significant reduction in attack frequency in the homeopathy group (P= 0.04) and non-statistically significant trends in favour of homeopathy for pain intensity and overall evaluation. Further research, with improved trial design, on the possible role of homeopathy in migraine prophylaxis is justified.


J Pain Symptom Manage. 1999 Nov;18(5):353-7.

Homeopathic prophylaxis of headaches and migraine? A systematic review.

Ernst E.

Department of Complementary Medicine, School of Postgraduate Medicine and Health Sciences, University of Exeter, United Kingdom.

Homeopathy is often advocated as a prophylaxis of migraine and headaches. The aim of this systematic review was to evaluate the clinical trials, testing the efficacy of homeopathy for these indications. Independent computerized literature searches were carried out in 4 databases. Only randomized, placebo-controlled trials were included. Four such studies were found. Their methodological quality was variable but, on average, satisfactory. One study suggested that homeopathic remedies were effective. The other, methodologically stronger trials did not support this notion. It is concluded that the trial data available to date do not suggest that homeopathy is effective in the prophylaxis of migraine or headache beyond a placebo effect.

Çàêëþ÷åíèå â öåëîì òàêîâî: â ïðîôèëàêòèêå ìèãðåíè ãîìåîïàòèÿ ìàëî ÷åì îòëè÷àåòñÿ îò ïëàöåáî (ïóñòûøêè).
  #45  
Ñòàðûé 08.10.2003, 11:49
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad âíå ôîðóìà
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,603
Ïîáëàãîäàðèëè 33,347 ðàç(à) çà 31,694 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êñòàòè î ïðîôèëàêòèêå:

íàïð. âîò êàê ñîâåòóþò ôðàíöóçû:

Rev Neurol (Paris). 2000;156 Suppl 4:4S79-86.
[Prophylactic treatments of migraine]
Massiou H.
Hopital Lariboisiere, Service de Neurologie, Paris.

The choice of the drug to start with depends on several considerations. The first step is to make sure that there are no contra indications, and no possible interaction with the abortive medications. Then, possible side effects will be taken into account, for example, weight gain is a problem for most young women and patients who practice sports may not tolerate betablockers. Associated pathologies have to be checked. For example, a hypertensive migraine sufferers may benefit from betablockers; in a patient who suffers both from migraine and tension type headaches or from depression, amitriptyline is the first choice drug. The type of migraine should also be considered;

**for instance, in frequent attacks with aura, aspirin is recommended and betablockers avoided.**

In most cases, prophylaxis should be given as monotherapy, and it is often necessary to try successively several drugs before finding the most appropriate one. Doses should be increased gradually, in order to reach the recommended daily dose, only if tolerance permits. The treatment efficacy has to be assessed after 2 or 3 months, during which the patient must keep a headache diary. If the drug is judged ineffective, an overuse of symptomatic medications should be checked, as well as a poor compliance, either of which may be responsible. In case of a successful treatment, it should be continued for 6 or 12 months, and then, one should try to taper off the dose in order to stop the treatment or at least to find the minimum active dose.

 òî æå âðåìÿ áåòà-áëîêàòîðû è áûëè óñïåøíî ïðèìåíåíû ïðè ïðîôèëàêòèêå ìèãðåíè ñ àóðîé.
Êðîìå òîãî, êàê íå ñïåöèàëèñò, çàòðóäíÿþñü îöåíèòü êàêîé æå òèï ãîëîâíûõ áîëåé ó Âàñ, à îò ýòîãî ìîæåò çàâèñåòü âûáîð ïðåïàðàòà. Â öåëîì, ïîõîæå, ëèøü ìåòîäîì ïðîá è ñîáëþäàÿ âûøåóêàçàííûå ïðàâèëà Âû òîëüêî ñàìè ìîæåòå ïîäîáðàòü "ñâîé" ïðåïàðàò è "ñâîþ" äîçó.
Çàêðûòàÿ òåìà



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 11:18.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.